SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)

$13.02 -0.29 (-2.1788%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 82

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) News Sources

Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains?

25-06-2026

yahoo.com

Silence Therapeutics plc (SLN) Initiated at Overweight as Analyst Highlights siRNA Pipeline Potential

30-06-2026

yahoo.com

Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera

09-08-2026

yahoo.com

Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results

10-08-2026

yahoo.com

Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

10-08-2026

yahoo.com

Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares

10-08-2026

yahoo.com

Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial

11-08-2026

marketbeat.com

Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering

12-08-2026

yahoo.com

Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs

14-08-2026

yahoo.com

Silence Therapeutics to Participate in Three September Investor Conferences

02-09-2026

yahoo.com

SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) Sentiment Trend

0 25 50 75 100 72 92 76 90 82 83 84 86 71 88 25-06-2026 30-06-2026 09-08-2026 10-08-2026 11-08-2026 12-08-2026 14-08-2026 02-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) FAQs

toggle

What is the current price of SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)?

The current price of SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) is $13.02.


toggle

SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) absolute price change since previous trading day?

The absolute price change of SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) since the previous trading day is $-0.29.


toggle

SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) percentage price change since previous trading day?

The percentage price change of SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) since the previous trading day is -2.1788%.


toggle

What is the most recent average sentiment score for SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)?

The most recent average sentiment score for SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) is 82 out of 100.


toggle

What is the most recent average sentiment for SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)?

The most recent sentiment for SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) is .


SEC-8K** Filing Available For SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.